Gazyva

Roche looks to grow Gazyva's reach with phase 3 lupus nephritis win
Fierce Pharma
Thu, 09/26/24 - 06:27 pm
Roche
Gazyva
clinical trials
lupus nephritis
FDA approves expanded use of BeiGene's blood cancer drug
Reuters
Thu, 03/7/24 - 05:30 pm
BeiGene
FDA
Brukinsa
Gazyva
In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment
Endpoints
Mon, 06/14/21 - 10:29 am
AstraZeneca
JNJ
AbbVie
clinical trials
CLL
Gazyva
Imbruvica
Venclexta
Roche steers Gazyva into a new PhIII program after combo shows promise in lupus nephritis study
Endpoints
Mon, 11/11/19 - 11:04 am
Roche
monoclonal antibodies
Gazyva
lupus
kidney disease
clinical trials
After touting Gazyva's potential in lupus, Roche nabs 'breakthrough' ahead of PhIII
Endpoints
Wed, 09/18/19 - 10:02 am
Roche
Gazyva
lupus nephritis
Roche touts phase 2 Gazyva data in lupus patients with a potentially fatal kidney complication
Fierce Pharma
Tue, 06/11/19 - 06:32 pm
Roche
FDA
lupus nephritis
Gazyva
ASCO Soundbites, vol. 3: Real-time approvals, Pfizer's second rodeo and 'the busiest ASCO ever'
Fierce Pharma
Tue, 06/4/19 - 12:18 pm
ASCO 2019
Merck
Keytruda
FDA
Pfizer
AstraZeneca
Regeneron
Libtayo
Venclexta
Gazyva
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
CP Wire
Thu, 03/7/19 - 09:53 am
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
Thu, 03/7/19 - 09:35 am
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
BioSpace
Mon, 01/28/19 - 12:11 pm
Imbruvica
Janssen
AbbVie
Roche
Gazyva
chronic lymphocytic leukemia
small lymphocytic lymphoma
FDA
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Thu, 11/1/18 - 11:28 am
Roche
Genentech
AbbVie
clinical trials
Venclexta
Gazyva
CLL
chronic lymphocytic leukemia
Priority Review for Imbruvica-Gazyva combo to treat CLL, SLL
BioCentury
Wed, 10/17/18 - 12:24 pm
AbbVie
FDA
priority review
Imbruvica
Gazyva
CLL
SLL
AbbVie eyes Imbruvica expansion in CLL as Gazyva pairing hits its marks
Fierce Pharma
Thu, 05/24/18 - 05:44 pm
AbbVie
Imbruvica
CLL
Gazyva
Cancer Space Update: Label Expansion for Three Major Drugs
Yahoo/Zacks.com
Fri, 11/17/17 - 11:45 am
cancer
labeling
AstraZeneca
Faslodex
Pfizer
Sutent
kidney cancer
Roche
Gazyva
follicular lymphoma
Late-stage study of Roche's Gazyva in large B-cell lymphoma fails to hit main goal
First Word Pharma
Mon, 07/18/16 - 10:55 am
Roche
Gazyva
large B-cell lymphoma
clinical trials
Roche's Hematology Franchise Almost 100% Protected From Biosimilars
Seeking Alpha
Fri, 05/27/16 - 10:59 pm
Roche
hematology
biosimilars
Gazyva
Rituxan
Roche's Gazyva notches early trial success
BioPharma Dive
Fri, 05/27/16 - 12:51 pm
Roche
Gazyva
clinical trials
rituximab
follicular lymphoma
Roche Holding Moves Ahead in Cancer Drugs Race; Wins Expanded FDA Approval for Gazyva
Bidness, ETC
Sat, 02/27/16 - 09:23 am
Roche
FDA
Gazyva
follicular lymphoma
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
biosimilars
AbbVie
Roche
Amgen
Rituxan
Herceptin
Avastin
Neupogen
Neulasta
Epogen
Humira
Perjeta
Gazyva
Roche's Gazyva doubles remission time for non-Hodgkin lymphoma patients
Fierce Pharma
Sat, 05/30/15 - 05:36 pm
Roche
Gazyva
non-Hodgkin's lymphoma
ASCO

Pages